Research graph
References from Manejo de la fibrilación auricular no valvular desde la perspectiva del paciente en España. Local targets link to admitted publications; unresolved targets remain external evidence.
Prevalencia de la fibrilación auricular en España. Resultados del estudio OFRECE
10.1016/j.recesp.2013.07.015 · 2014 · External reference
Unresolved reference
2017 · External reference
Prevalencia de fibrilación auricular y características de la fibrilación auricular no valvular en la población general. Registro AFINVA
2017 · External reference
Caracterización de pacientes con fibrilación auricular no valvular diagnosticada y no tratada con anticoagulantes orales. ESCONDIDA FA
2017 · External reference
Mixed treatment comparison meta-analysis of Aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation
10.1016/j.clinthera.2013.05.011 · 2013 · External reference
Patients’ and physicians’ perceptions and attitudes about oral anticoagulation and atrial fibrillation: A qualitative systematic review
10.1186/s12875-016-0574-0 · 2017 · External reference
Oral anticoagulant therapy
10.1378/chest.11-2292 · 2012 · External reference
Systematic overview of warfarin and its drug and food interactions
10.1001/archinte.165.10.1095 · 2005 · External reference
Vitamin K antagonists: Relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
2016 · External reference
Unresolved reference
External reference
Acceso a los anticoagulantes de acción directa en España
2016 · External reference
What is value in health care?
10.1056/nejmp1011024 · 2010 · External reference
Patient perspective on the management of atrial fibrillation in five European countries
10.1186/1471-2261-13-108 · 2013 · External reference
10.1093/eurheartj/ehw210
10.1093/eurheartj/ehw210 · 2016 · External reference
Unresolved reference
External reference
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
10.1093/eurheartj/ehs253 · 2012 · External reference
2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
2014 · External reference
Best practice for atrial fibrillation patient education
10.2174/1381612820666140825125715 · 2014 · External reference
Unresolved reference
External reference
Uso de los anticoagulantes orales de acción directa en atención primaria: Estudio ACTUA
10.1016/j.semerg.2016.09.003 · 2017 · External reference
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation
10.1177/1074248415596426 · 2016 · External reference
Posicionamiento de SEMERGEN sobre la utilización de los anticoagulantes orales de acción directa
2017 · External reference
Unresolved reference
External reference
How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey
10.1093/europace/euv025 · 2015 · External reference
Patient preferences for oral anticoagulation therapy in atrial fibrillation: A systematic literature review
10.1007/s40271-016-0185-9 · 2017 · External reference
Patient perspectives on taking vitamin K antagonists: A qualitative study in the UK, USA and Spain
10.1586/erp.09.48 · 2009 · External reference
Grado de satisfacción con el cuidado médico de los pacientes con fibrilación auricular no valvular que toman antagonistas de la vitamina k o anticoagulantes directos: un estudio comparativo
10.1016/j.recesp.2015.02.005 · 2015 · External reference
Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain
10.1016/j.medcli.2016.05.024 · 2016 · External reference
